← Back to Search

Financial Incentives for Alzheimer's Prevention (FIND-AD Trial)

N/A
Recruiting
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 50 or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying the impact of different types of messages and financial incentives on getting a diverse group of people to enroll in an online study about Alzheimer's prevention. The study will work with a public hospital

Who is the study for?
This trial is for individuals aged 50 or older who are patients at Contra Costa Regional Medical Center and its affiliated health centers. Participants must be literate in English or Spanish. The study aims to recruit a diverse group of people into an online Alzheimer's disease registry.
What is being tested?
The study is testing if sending messages with financial incentives, such as small cash rewards or prize drawings, can increase enrollment in the APT Webstudy—a remote cognitive testing program—compared to just sending messages without incentives.
What are the potential side effects?
Since this trial involves non-medical interventions like financial incentives and messaging, there are no direct medical side effects associated with participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 50 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Enrollment status into the APT Webstudy
Secondary study objectives
Completion of cognitive assessments within the APT Webstudy
Cost per enrollee

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Small IncentiveExperimental Treatment1 Intervention
16,000 participants will be randomized to Arm 2 where a small one-time monetary incentive is offered.
Group II: Prize IncentiveExperimental Treatment1 Intervention
16,000 participants will be randomized to Arm 3 where an opportunity based incentive (or a drawing with a prize) with a single winner will be offered.
Group III: Messaging OnlyActive Control1 Intervention
16,000 participants will be randomized to Arm 1 where no monetary incentive is offered.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Financial Incentives
2018
Completed Phase 2
~11680

Find a Location

Who is running the clinical trial?

American Heart AssociationOTHER
346 Previous Clinical Trials
4,923,187 Total Patients Enrolled
Schaeffer Center for Health Policy & EconomicsUNKNOWN
University of Southern CaliforniaLead Sponsor
946 Previous Clinical Trials
1,556,619 Total Patients Enrolled
Alzheimer's Therapeutic Research InstituteOTHER
17 Previous Clinical Trials
10,362 Total Patients Enrolled
~23172 spots leftby Mar 2026